GSTM1 and hemoglobinopathy: Generally, the protocol for hemoglobinopathy screening includes the whole blood count followed by the determination of hemoglobin A2 (HbA2) and hemoglobin F (HbF) levels, as well as the identification of any rare variant present by Hb electrophoresis or high performance liquid chromatography.